Strathmore University Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2016
NCT02746276
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Centre for Research in Therapeutic Sciences, Strathmore University, Nairobi Kenya | KEMRI/CREATES, Strathmore University | Strathmore University

Active Ingredients

Drugs in Phase 2 Trials (2)

ceftriaxone (rocephin) (1 trial)

metronidazole (flagyl) (1 trial)

Drugs in Other Trials (1)

zinc sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malnutrition (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3